These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 6108567

  • 1. Does neuroleptic blocking of dopamine receptors continue after chronic treatment?
    Belmaker RH, Dasberg H, Ebstein RP.
    Prog Biochem Pharmacol; 1980; 16():109-18. PubMed ID: 6108567
    [Abstract] [Full Text] [Related]

  • 2. Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.
    Jenner P, Kerwin R, Rupniak NM, Murugaiah K, Hall MD, Fleminger S, Marsden CD.
    J Neural Transm Suppl; 1983; 18():205-12. PubMed ID: 6135741
    [Abstract] [Full Text] [Related]

  • 3. Chronic haloperidol does not increase specific dopamine receptor binding in rat frontal cortex.
    Meller E, Bohmaker K, Rosengarten H, Friedhoff AJ.
    Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):323-32. PubMed ID: 7178646
    [Abstract] [Full Text] [Related]

  • 4. Effects of chronic administration of neuroleptic and anticholinergic agents on densities of D2 dopamine and muscarinic cholinergic receptors in rat striatum.
    Boyson SJ, McGonigle P, Luthin GR, Wolfe BB, Molinoff PB.
    J Pharmacol Exp Ther; 1988 Mar; 244(3):987-93. PubMed ID: 2908050
    [Abstract] [Full Text] [Related]

  • 5. Dopamine binding following prolonged haloperidol pretreatment.
    Hitri A, Weiner WJ, Borison RL, Diamond BI, Nausieda PA, Klawans HL.
    Ann Neurol; 1978 Feb; 3(2):134-40. PubMed ID: 655662
    [Abstract] [Full Text] [Related]

  • 6. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
    Bacopoulos NG.
    J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752
    [Abstract] [Full Text] [Related]

  • 7. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.
    Schweitzer JW, Schwartz R, Friedhoff AJ.
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):21-30. PubMed ID: 7146618
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA, Marsh CL.
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Decreased adenosine cyclic 3',5'-monophosphate phosphodiesterase activity in rat straitum following chronic haloperidol treatment.
    Fredholm BB.
    Med Biol; 1977 Feb; 55(1):61-5. PubMed ID: 191703
    [Abstract] [Full Text] [Related]

  • 13. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
    Zahniser NR, Molinoff PB.
    Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
    [Abstract] [Full Text] [Related]

  • 14. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA, Lestienne F, Grevoz-Barret C, Newman-Tancredi A, Cussac D.
    Eur J Pharmacol; 2009 Oct 12; 620(1-3):27-35. PubMed ID: 19695244
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Individual differences in the response of dopamine receptor number to chronic haloperidol treatment.
    Bannet J, Belmaker RH, Ebstein RP.
    Biol Psychiatry; 1981 Nov 12; 16(11):1059-65. PubMed ID: 7349620
    [Abstract] [Full Text] [Related]

  • 17. Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains.
    Noga JT, Hyde TM, Herman MM, Spurney CF, Bigelow LB, Weinberger DR, Kleinman JE.
    Synapse; 1997 Nov 12; 27(3):168-76. PubMed ID: 9329152
    [Abstract] [Full Text] [Related]

  • 18. Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine.
    Sprah L, Zivin M, Sket D.
    J Pharmacol Exp Ther; 1999 Mar 12; 288(3):1093-100. PubMed ID: 10027846
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia.
    Wolkin A, Barouche F, Wolf AP, Rotrosen J, Fowler JS, Shiue CY, Cooper TB, Brodie JD.
    Am J Psychiatry; 1989 Jul 12; 146(7):905-8. PubMed ID: 2568094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.